Literature DB >> 20689991

Pulmonary hemorrhage in type 3 Gaucher disease: a case report.

Ashok Vellodi1, Michael Ashworth, Niamh Finnegan, Colin Wallis.   

Abstract

A 2-year-old boy with type 3 Gaucher disease (GD) on treatment with enzyme replacement therapy (ERT) was found dead in bed having been apparently well the night before. At the time of diagnosis, he had significant respiratory symptoms (severe and persistent bouts of coughing) that had been attributed to Gaucher lung infiltration and that were controlled by inhaled and orally administered steroids. These symptoms had begun to reappear just prior to death. Postmortem revealed extensive pulmonary hemorrhage and intra-alveolar collections of Gaucher cells. There was very little evidence of GD elsewhere. Death was ascribed to pulmonary hemorrhage secondary to GD. The pathogenesis was unclear. To the best of our knowledge, this is the first case of isolated pulmonary hemorrhage secondary to GD and may represent a hitherto unrecognized complication of this condition. Given the apparent temporal relationship, we propose that it represented a severe, terminal event in the course of Gaucher lung disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20689991     DOI: 10.1007/s10545-010-9176-5

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  12 in total

Review 1.  Management of neuronopathic Gaucher disease: a European consensus.

Authors:  A Vellodi; B Bembi; T B de Villemeur; T Collin-Histed; A Erikson; E Mengel; A Rolfs; A Tylki-Szymanska
Journal:  J Inherit Metab Dis       Date:  2001-06       Impact factor: 4.982

Review 2.  Pulmonary involvement of Gaucher's disease in children: a common presentation in Saudi Arabia.

Authors:  H Banjar
Journal:  Ann Trop Paediatr       Date:  1998-03

3.  Severe pulmonary involvement in adult Gaucher's disease. Report of three cases and review of the literature.

Authors:  E L Schneider; C J Epstein; M J Kaback; D Brandes
Journal:  Am J Med       Date:  1977-09       Impact factor: 4.965

4.  Pulmonary function abnormalities in type I Gaucher disease.

Authors:  E Kerem; D Elstein; A Abrahamov; Y Bar Ziv; I Hadas-Halpern; E Melzer; C Cahan; D Branski; A Zimran
Journal:  Eur Respir J       Date:  1996-02       Impact factor: 16.671

Review 5.  Response of Gaucher bone disease to enzyme replacement therapy.

Authors:  L W Poll; M Maas; M R Terk; M Roca-Espiau; B Bembi; G Ciana; N J Weinreb
Journal:  Br J Radiol       Date:  2002       Impact factor: 3.039

6.  Acute neuronopathic Gaucher disease complicated by fatal gastrointestinal bleeding.

Authors:  B Hoffmann; B Schwahn; C B Knobbe; M Vogel; M Blohm; E Mayatepek; U Wendel
Journal:  Neuropediatrics       Date:  2006-06       Impact factor: 1.947

7.  Lung involvement and enzyme replacement therapy in Gaucher's disease.

Authors:  O Goitein; D Elstein; A Abrahamov; I Hadas-Halpern; E Melzer; E Kerem; A Zimran
Journal:  QJM       Date:  2001-08

8.  Pulmonary pathology in Gaucher's disease.

Authors:  G Amir; N Ron
Journal:  Hum Pathol       Date:  1999-06       Impact factor: 3.466

9.  Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy.

Authors:  T Andrew Burrow; Mitchell B Cohen; Ronald Bokulic; Gail Deutsch; Arabinda Choudhary; Richard A Falcone; Gregory A Grabowski
Journal:  J Pediatr       Date:  2007-02       Impact factor: 4.406

Review 10.  Recombinant glucocerebrosidase (imiglucerase) as a therapy for Gaucher disease.

Authors:  Gregory M Pastores
Journal:  BioDrugs       Date:  2010-02-01       Impact factor: 5.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.